IP Library Patent Application 12966026
Patent Application
App. No. 12/966,026

Smoking Cessation Lozenge Containing Tobacco Alkaloid And Silver Salt

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/966,026
Abstract

A smoking cessation aid is in the form of a lozenge containing powdered tobacco and a therapeutically effective amount of a silver salt. In another embodiment, a lozenge contains nicotine and a therapeutically effective amount of a silver salt. In yet another embodiment, a lozenge contains (i) at least one of anatabine, anabasine, and nornicotine, and (ii) a therapeutically effective amount of a silver salt.

Claims (20)

1 . A smoking cessation aid comprising a lozenge containing powdered tobacco and a therapeutically effective amount of a silver salt.

2 . The smoking cessation aid of claim 1 wherein the silver salt is silver acetate.

3 . The smoking cessation aid of claim 2 wherein silver acetate is present in an amount from about 1 to about 10 mg.

4 . The smoking cessation aid of claim 1 wherein the powdered tobacco consists essentially of Virginia flue cured tobacco.

5 . The smoking cessation aid of claim 1 wherein the powdered tobacco consists essentially of Burley tobacco.

6 . The smoking cessation aid of claim 1 wherein the powdered tobacco consists essentially of dark-fired tobacco.

7 . The smoking cessation aid of claim 1 wherein the powdered tobacco comprises a blend of at least two varieties selected from the group consisting of Virginia flue cured tobacco, Burley tobacco, and dark-fired tobacco.

8 . The smoking cessation aid of claim 1 wherein said powdered tobacco comprises pulverized tobacco.

9 . The smoking cessation aid of claim 1 wherein said powdered tobacco is prepared from an extract of tobacco.

10 . A smoking cessation aid comprising a lozenge containing nicotine and a therapeutically effective amount of a silver salt.

11 . The smoking cessation aid of claim 10 wherein the silver salt is silver acetate.

12 . The smoking cessation aid of claim 11 wherein silver acetate is present in an amount from about 1 to about 10 mg.

13 . The smoking cessation aid of claim 11 wherein nicotine is present in an amount from about 1 to about 5 mg.

14 . The smoking cessation aid of claim 13 wherein nicotine is present in an amount from about 2 to about 4 mg.

15 . A smoking cessation aid comprising a lozenge containing (i) at least one of anatabine, anabasine, and nornicotine, and (ii) a therapeutically effective amount of a silver salt.

16 . The smoking cessation aid of claim 15 wherein the silver salt is silver acetate.

17 . The smoking cessation aid of claim 16 wherein silver acetate is present in an amount from about 1 to about 10 mg.

18 . The smoking cessation aid of claim 15 wherein anatabine is present in an amount from about 0.25 to about 4 mg.

19 . The smoking cessation aid of claim 15 wherein anabasine is present in an amount from about 0.25 to about 4 mg.

20 . The smoking cessation aid of claim 15 wherein nornicotine is present in an amount from about 0.25 to about 4 mg.

Assignments (2)
CHANGE OF NAME Recorded Jul 14, 2014
From: ROCK CREEK PHARMACEUTICALS, INC.
To: RCP DEVELOPMENT, INC.
Reel/Frame 033309/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2010
From: WRIGHT IV, MD, CURTIS, MPH
To: ROCK CREEK PHARMACEUTICALS, INC.
Reel/Frame 025475/0291 →